Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
948.4 USD | -0.21% | +1.85% | +62.92% |
02:35pm | Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793 | MT |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.92% | 86TCr | |
+38.95% | 63TCr | |
-4.01% | 36TCr | |
+16.07% | 32TCr | |
+8.90% | 30TCr | |
+5.89% | 23TCr | |
+16.53% | 23TCr | |
+15.54% | 18TCr | |
+1.85% | 16TCr | |
+2.41% | 13TCr |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Blacksmith Medicines Enters into Research Collaboration with Lilly